Sign up to save your podcasts
Or
Share Dr Elhassadi Highlights the Impact of a p53 Alteration in Patients With MCL
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Dr Elhassadi Highlights the Impact of a p53 Alteration in Patients With MCL
Ezzat Elhassadi, MD, Consultant Hematologist, University Hospital, Waterford, Ireland, discusses the impact of a p53 alteration in patients with mantle cell lymphoma (MCL); these data were presented at the EHA2021 Virtual Congress.
View all episodes
By HMP GlobalEzzat Elhassadi, MD, Consultant Hematologist, University Hospital, Waterford, Ireland, discusses the impact of a p53 alteration in patients with mantle cell lymphoma (MCL); these data were presented at the EHA2021 Virtual Congress.